Dynamic Metabolic Changes during the First 3 Months after 90Y-Ibritumomab Tiuxetan Radioimmunotherapy
Figure 3
Average percent decrease in relative to baseline values as a function of time after RIT. Error bars represent standard deviations, with negative error bars on the -axis omitted.